About Enhancer
| Enhancer ID: | E_01012 |
| Species: | Homo sapiens |
| Position : | chr11:8254932-8255884   |
| Year: | 2019 |
| Title: | LMO1 Super-Enhancer rs2168101 G>T Polymorphism Reduces Wilms Tumor Risk |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | thyroid carcinoma |
| PMID: | 31205537 |
| MONDO: | MONDO:0005075 |
| Tissue: | Thyroid |
| Tissue Ontology ID: | UBERON:0002046 |
| Cell Source: | BCPAP |
| CVCL ID: | CVCL_0153 |
| Cell Type: | thyroid carcinoma cell |
| Cell Ontology ID: | CL:0000066 |
| Experiment Type: | Enhancer expression quantitative trait locus assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | TaqMan Genotyping Assay, RT-RT-qPCR |
About Target Gene
| Target gene : | LMO1 |
About TF
| TF name : |
About Regulatory State
| Regulatory State : | Active |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|
Enhancer Associated Network
Overlapping Enhancers (hg19)
No overlapping enhancers found in hg19 at this locus.
Expression of Target Genes for the Enhancer